6.28
Scisparc Ltd stock is traded at $6.28, with a volume of 248.61K.
It is down -6.13% in the last 24 hours and up +1,939% over the past month.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$6.69
Open:
$6.45
24h Volume:
248.61K
Relative Volume:
0.14
Market Cap:
$3.36M
Revenue:
$1.75M
Net Income/Loss:
$-5.68M
P/E Ratio:
-1.2888
EPS:
-4.8726
Net Cash Flow:
-
1W Performance:
-21.53%
1M Performance:
+1,939%
6M Performance:
+1,322%
1Y Performance:
+1,206%
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SPRC
Scisparc Ltd
|
6.28 | 3.58M | 1.75M | -5.68M | 0 | -4.8726 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd Stock (SPRC) Latest News
SciSparc sets shareholder vote dates for AutoMax merger By Investing.com - Investing.com South Africa
SciSparc Announces Updates Regarding Proposed Merger; Form - GlobeNewswire
SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors - Stock Titan
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Breakthrough Patent: New Drug Combination Targets 890M Obesity Patients and Fatty Liver Disease - Stock Titan
Best data tools to analyze SciSparc Ltd. stockFree Buy Low Sell High Stock Watch - Newser
Moving Average Trends for SciSparc Ltd. Stock: What They IndicateSmart Forecast Signals from AI Models - Newser
Evaluating SciSparc Ltd. with trendline analysisFree Day Trading Signals With High Precision - Newser
Quantitative breakdown of SciSparc Ltd. recent moveFree Trade Setups With Clear Risk Limits - Newser
What moving averages say about SciSparc Ltd.Free Expert Verified Stock Trade Ideas - Newser
Does SciSparc Ltd. stock pay reliable dividendsWeekly Stock Picks with Trend Confidence - Newser
SciSparc Ltd.’s Price Action Aligns with Quant SignalsRisk Controlled Picks With Real Returns Outlined - beatles.ru
Will SciSparc Ltd. Stock Benefit from AI and Green Energy TrendsEarnings Based Stock Performance Forecast - Newser
How SciSparc Ltd. stock performs during market volatilityTrade Setup Builder with Custom Alerts - Newser
SciSparc Ltd. Could See a Relief Rally From SupportEntry Alert Based on Volume Spikes Detected - metal.it
How does SciSparc Ltd. compare to its industry peersPowerful profit generation - jammulinksnews.com
Is SciSparc Ltd. a growth stock or a value stockAchieve breakthrough performance with smart picks - jammulinksnews.com
What is the dividend policy of SciSparc Ltd. stockInvest smarter with expert trading signals - jammulinksnews.com
Is it the right time to buy SciSparc Ltd. stockInvest confidently with real-time data - jammulinksnews.com
What catalysts could drive SciSparc Ltd. stock higher in 2025Financial News Tips For Beginners - jammulinksnews.com
What moving averages say about SciSparc Ltd. AI Intraday Market Movement Prediction Tool - Newser
Should I hold or sell SciSparc Ltd. stock in 2025Invest smarter and grow your wealth faster - jammulinksnews.com
What makes SciSparc Ltd. stock price move sharplyHigh Return Stock Alerts - metal.it
SciSparc Ltd. Earnings Report Breakdown: What Investors Should KnowChart Based Entries - Newser
Why SciSparc Ltd. stock attracts strong analyst attentionDaily Swing Candidates - Newser
What analysts say about SciSparc Ltd. stockConsistent double returns - Autocar Professional
What drives SciSparc Ltd. stock priceSpectacular growth rates - Autocar Professional
SciSparc regains compliance with Nasdaq’s listing rule - MSN
Is SciSparc Ltd. a good long term investmentExponential return rates - jammulinksnews.com
SciSparc regains compliance with Nasdaq minimum bid price notification - TipRanks
SciSparc Ltd. Executes Reverse Share Split Amid Financial Challenges - TipRanks
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification - mg Magazine
IKNA issues special CVR dividend ahead of Inmagene merger | SPRC SEC FilingForm F-3/A - Stock Titan
SciSparc Ltd. Stock Analysis and ForecastRapid capital growth - jammulinksnews.com
SciSparc Ltd. Regains Nasdaq Compliance - TipRanks
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):